Acute Pain Market Forecast Signals Accelerated Growth at a CAGR of 12% During the Forecast Period (2026-2036), Driven by Novel Non-Opioid Therapies and Expanding Treatment Options | DelveInsight

Summary

DelveInsight projects the acute pain market will grow at a 12% CAGR from 2026-2036, driven by adoption of multimodal pain management approaches and non-opioid therapies including emerging products like Rizatriptan (RizaFilm).